Flublok v. Standard Dose Vaccine Effectiveness Among Kaiser Permanente Northern California Adults 18-64 Years

NCT03694392 · clinicaltrials.gov ↗

COMPLETED

Status

2776278

Enrollment

OTHER

Sponsor class

Conditions

Influenza
Pneumonia
Lower Respiratory Tract Infection
Acute Myocardial Infarction
Congestive Heart Failure
Stroke

Interventions

BIOLOGICAL: Flublok Quadrivalent
BIOLOGICAL: Standard Dose Inactivated Influenza Vaccine (SD-IIV)

Sponsor

Kaiser Permanente

Collaborators

[object Object]